Xencor to Host Third Quarter 2020 Financial Results Webcast and Conference Call on November 5, 2020 Read more about Xencor to Host Third Quarter 2020 Financial Results Webcast and Conference Call on November 5, 2020
Xencor to Present Data from the Phase 1 Study of XmAb®20717 and Three Research Programs at the SITC Annual Meeting Read more about Xencor to Present Data from the Phase 1 Study of XmAb®20717 and Three Research Programs at the SITC Annual Meeting
Xencor Presents Initial Data From the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium Read more about Xencor Presents Initial Data From the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium
Xencor to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference Read more about Xencor to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
Xencor to Present Initial Data from the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium Read more about Xencor to Present Initial Data from the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium
Xencor and MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb® Drug Candidates Read more about Xencor and MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb® Drug Candidates
Xencor to Present at Upcoming Investor Conferences Read more about Xencor to Present at Upcoming Investor Conferences
Xencor Reports Second Quarter 2020 Financial Results Read more about Xencor Reports Second Quarter 2020 Financial Results
Xencor Earns Milestone Payment from MorphoSys for FDA Approval of Monjuvi® (tafasitamab-cxix) in the United States Read more about Xencor Earns Milestone Payment from MorphoSys for FDA Approval of Monjuvi® (tafasitamab-cxix) in the United States
Xencor to Host Second Quarter 2020 Financial Results Webcast and Conference Call on August 4, 2020 Read more about Xencor to Host Second Quarter 2020 Financial Results Webcast and Conference Call on August 4, 2020
